Cypress Capital Group Q3 2023 vs. Q4 2023 13F Holdings Comparison

Cypress Capital Group, a prominent investment firm, recently released its Q3 2023 and Q4 2023 13F holdings, detailing the changes in their investment portfolio. In this blog post, we will analyze the notable shifts and provide insights into the potential reasons behind these changes.

APPLE INC (AAPL)

Cypress Capital Group reduced its holdings in Apple Inc by 7,877 shares, representing a decrease of 3.5% from Q3 to Q4 2023. The value of their Apple holdings also declined by $2,297,000 during the same period. This reduction may be attributed to various factors, such as a change in the overall market sentiment towards the technology sector or a reallocation of funds into other investment opportunities.

ISHARES TR (IVV)

The investment in iShares TR, an exchange-traded fund, saw a significant increase in Q4 2023, with Cypress Capital Group adding 26,630 shares. This represents a substantial growth of 70.3% compared to their Q3 2023 holdings. The value of their investments in iShares TR also rose by $15,136,000 during this period. This move suggests that Cypress Capital Group may have identified new opportunities in the broader market and decided to allocate a larger portion of their portfolio to this ETF.

ELI LILLY & CO (LLY)

Cypress Capital Group slightly reduced its holdings in Eli Lilly & Co by 2,112 shares, corresponding to a decrease of 3.9% in Q4 2023. The value of their investments in this pharmaceutical company also experienced a slight decline of $482,000. This adjustment may be due to various factors, including changes in the company's performance or a strategic decision to rebalance the portfolio.

MICROSOFT CORP (MSFT)

There was a negligible change in Cypress Capital Group's holdings in Microsoft Corp, with only 97 shares being sold in Q4 2023. This marginal adjustment doesn't significantly impact their overall investment in the tech giant. It is worth noting that the value of their holdings in Microsoft Corp increased by $5,073,000 during this period, indicating positive market performance.

VISA INC (V)

Cypress Capital Group slightly reduced its holdings in Visa Inc by 1,823 shares, reflecting a decrease of 2.3% from Q3 to Q4 2023. The value of their investments in Visa also experienced a marginal decline of $907,000. This adjustment may be attributed to various factors, including changes in the market outlook for the financial sector or a strategic decision to reallocate funds.

ABBVIE INC (ABBV)

The investment in AbbVie Inc by Cypress Capital Group saw a modest decline of 1,061 shares in Q4 2023, representing a decrease of 0.9% from their Q3 holdings. The value of their AbbVie investments also decreased slightly by $498,000 during this period. This adjustment may be the result of market fluctuations or a strategic decision to reallocate resources across the portfolio.

LOCKHEED MARTIN CORP (LMT)

Cypress Capital Group reduced its holdings in Lockheed Martin Corp by 494 shares, representing a decrease of 1.4% in Q4 2023. However, the value of their investments in this aerospace and defense company increased by $1,317,000, indicating positive market performance. The slight reduction in shares may be due to factors specific to the industry or a reallocation of funds to other opportunities within the sector.

ISHARES TR (IJH)

Cypress Capital Group significantly increased its holdings in iShares TR in Q4 2023 by 26,906 shares, representing an impressive growth rate of 120.7% compared to their Q3 holdings. The value of their investments in this ETF also surged by $8,216,000 during this period. This notable increase suggests that the investment firm has recognized potential in the broader market and decided to allocate a larger portion of their portfolio to this ETF.

JOHNSON & JOHNSON (JNJ)

Cypress Capital Group maintained a relatively stable position in Johnson & Johnson, with only a marginal decrease of 67 shares in Q4 2023. This slight adjustment doesn't significantly impact their overall investment in the pharmaceutical company. The value of their holdings in Johnson & Johnson remained relatively unchanged during this period, indicating a neutral market performance.

JPMORGAN CHASE & CO (JPM)

There was a slight reduction in Cypress Capital Group's holdings in JPMorgan Chase & Co by 1,389 shares, reflecting a decrease of 1.9% in Q4 2023. The value of their investments in this banking giant also experienced a marginal decline of $595,000. This adjustment may be attributed to changes in the overall market outlook for the financial sector or a strategic decision to reallocate resources within the portfolio.

Conclusion

Cypress Capital Group's Q3 2023 vs. Q4 2023 13F holdings reveal some noteworthy changes in their investment portfolio. While there were minor adjustments in certain holdings, other investments experienced significant growth. These changes may reflect shifts in market sentiment, reallocation of funds, or the identification of new investment opportunities. It is essential to monitor these developments and analyze them in the context of broader market trends to gain a comprehensive understanding of Cypress Capital Group's investment strategy.